CVS Health (CVS) Tops Q4 EPS by 9c, FY EPS Guidance Misses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
CVS Health Reports Fourth Quarter and Full Year Results and Provides 2019 Full Year Guidance
February 20, 2019 6:55 AM ESTWOONSOCKET, R.I., Feb. 20, 2019 /PRNewswire/ --
Fourth Quarter Year-over-Year Highlights:
Completed $70 billion acquisition of Aetna Revenues (1) increased 12.5% to $54.4 billion GAAP diluted earnings (loss) per share from continuing operations of $(0.37), including a $2.2 billion, or $(1.99) per share, goodwill impairment charge related to the Long-Term Care ("LTC") business Adjusted EPS of $2.14Full Year Highlights:
Revenues (1) increased 5.3% to $194.6 billion GAAP diluted earnings (loss) per share from continuing operations of $(0.57), including $6.1 billion, or $(5.89) per share, of goodwill impairment... More